Market Cap 96.27M
Revenue (ttm) 10.09M
Net Income (ttm) -130.04M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,288.80%
Debt to Equity Ratio 0.05
Volume 850,800
Avg Vol 1,447,260
Day's Range N/A - N/A
Shares Out 6.44M
Stochastic %K 60%
Beta 1.50
Analysts Strong Sell
Price Target $60.00

Latest News on TNXP

Top 2 Health Care Stocks That Are Ticking Portfolio Bombs

Mar 25, 2025, 8:16 AM EDT - 4 weeks ago

Top 2 Health Care Stocks That Are Ticking Portfolio Bombs

ARQT


Tonix Pharmaceuticals Announces 1-for-100 Reverse Stock Split

Feb 3, 2025, 8:05 AM EST - 2 months ago

Tonix Pharmaceuticals Announces 1-for-100 Reverse Stock Split


Tonix Pharmaceuticals to Present at BIO-Europe® 2024

Oct 29, 2024, 8:00 AM EDT - 6 months ago

Tonix Pharmaceuticals to Present at BIO-Europe® 2024